Eran Hornstein, PhD
Eran Hornstein, PhD
Weizmann Institute of Science
Rehovot, Israel
Characterizing IL-18 Pathway Inhibitors as Therapeutics for ALS
This project aims to test IL-18 receptor function in human C90rf72 models of ALS and to test Il-18 pathway inhibitors as therapeutic for patients with ALS based on recent genetics discoveries from the Hornstein lab at Weizmann Institute of Science.
